A double-blind, randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes.


Autoria(s): Barbosa,L; Berk,M; Vorster,M
Data(s)

01/04/2003

Resumo

Evidence of the antidepressant efficacy of lamotrigine is increasing, although there are no placebo-controlled trials of lamotrigine augmentation in depression. The aim of this study was to assess if augmentation with lamotrigine was superior to placebo in patients who were receiving fluoxetine for resistant major depressive episodes.

Identificador

http://hdl.handle.net/10536/DRO/DU:30071277

Idioma(s)

eng

Publicador

Physicians Postgraduate Press

Relação

http://www.ncbi.nlm.nih.gov/pubmed/12716240

Direitos

2003, Physicians Postgraduate Press

Palavras-Chave #Social Sciences #Science & Technology #Life Sciences & Biomedicine #Psychology, Clinical #Psychiatry #Psychology #PSYCHIATRY, SCI #PSYCHIATRY, SSCI #RAPID CYCLING PATIENTS #BIPOLAR DISORDER #EFFICACY #MONOTHERAPY
Tipo

Journal Article